Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Profiling Immune-Independent Response to Immune Checkpoint Inhibitors on Stem Cell-Derived Cardiomyocytes, Organoids, and Mouse Models.

Circulation·2026
Same author

Multiscale profiling of tyrosine kinase inhibitor cardiotoxicity reveals mechanosensitive ion channel PIEZO1 as cardioprotective.

Science translational medicine·2025
Same author

Decoding long COVID-associated cardiovascular dysfunction: Mechanisms, models, and new approach methodologies.

Journal of molecular and cellular cardiology·2025
Same author

Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis.

Nature·2025
Same author

Generation of induced pluripotent stem cell line from a patient with long COVID.

Stem cell research·2025
Same author

CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity.

Cell stem cell·2024

Related Experiment Video

Updated: Sep 14, 2025

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

2.7K

Integrative approaches in cardiac tissue engineering: Bridging cellular complexity to create accurate physiological

Dilip Thomas1, Joseph C Wu1,2,3

  • 1Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.

Iscience
|July 23, 2025
PubMed
Summary

Cardiac tissue engineering needs genomic mapping to replicate heart niches for better regeneration and disease models. Innovations are advancing, but maturity and cell communication remain challenges for clinical translation.

Keywords:
BioengineeringBiomaterialsCardiovascular medicineTissue engineering

More Related Videos

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.1K
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.7K

Related Experiment Videos

Last Updated: Sep 14, 2025

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues
12:28

Designing a Bioreactor to Improve Data Acquisition and Model Throughput of Engineered Cardiac Tissues

Published on: June 2, 2023

2.7K
Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform
10:42

Developing 3D Organized Human Cardiac Tissue within a Microfluidic Platform

Published on: June 15, 2021

5.1K
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
10:37

Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells

Published on: March 14, 2021

6.7K

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Biotechnology

Background:

  • Cardiac tissue engineering (TE) aims to replicate the heart's complex cellular and extracellular matrix (ECM) environment.
  • Current TE approaches struggle to integrate genomic insights of cellular niches for precise replication.
  • Challenges include achieving optimal maturity, functional multicellular crosstalk, vascularization, innervation, and immune integration.

Purpose of the Study:

  • To review current understanding of cardiac cellular/ECM heterogeneity.
  • To synthesize progress in recapitulating cardiac features using advanced TE methods.
  • To provide a roadmap for future cardiac TE innovations.

Main Methods:

  • Critical evaluation of existing literature on cardiac cellular and ECM heterogeneity.
  • Synthesis of recent advancements in iPSC-derived models, biomaterials, and 3D bioprinting for cardiac constructs.
  • Analysis of challenges and emerging innovations in precision cardiac TE.

Main Results:

  • Cardiac TE innovations have advanced, but replicating the native heart's complexity remains difficult.
  • Existing models often lack sufficient cellular maturity and functional multicellular crosstalk.
  • Genomic mapping of cellular niches is crucial for replicating spatial organization and microniches.

Conclusions:

  • Addressing cardiac cellular/ECM heterogeneity is key to improving TE platforms.
  • Integrating genomic data with advanced TE techniques can enhance cardiac regeneration and disease modeling.
  • A roadmap is proposed to guide future research towards clinically transformative cardiac TE solutions.